A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin

FEMS Immunology and Medical Microbiology

Volumn 55, Issue 2, 2009, Pages 280-291

  Ekong, Eno E ^a   Okenu, Daniel N ^a   Mania Pramanik, Jayanti ^a,b   He, Qing ^a   Igietseme, Joseph U ^a,c   Ananaba, Godwin A ^d   Lyn, Deborah ^a   Black, Carolyn ^c   Eko, Francis O ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

Adjuvant; Antibodies; Cytokines; Protection; Vaccination

Indexed keywords

BACTERIAL VACCINE; CHLAMYDIA VACCINE; CHOLERA TOXIN; CHOLERA TOXIN A2B SUBUNIT; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; OUTER MEMBRANE PROTEIN; PLASMID VECTOR; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; CD4+ T LYMPHOCYTE; CHLAMYDIA; CHLAMYDIASIS; CONFERENCE PAPER; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOMODULATION; INFECTION RESISTANCE; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; VACCINATION; VACCINE PRODUCTION; VAGINITIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CHOLERA TOXIN; FEMALE; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MUCOUS MEMBRANE; PORINS; SPLEEN; T-LYMPHOCYTES; VACCINES, SUBUNIT; VAGINA; VIBRIO CHOLERAE;

EID: 60049093592     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00493.x     Document Type: Conference Paper

References (53)

1. Anjuere F, George-Chandy A, Auduant F, Rousseau D, Holmgren J Czerkinsky C (2003) Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses. J Immunol 170 : 1586 1592.
2. Batteiger BE, Rank RG, Bavoil PM Soderberg LSF (1993) Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis. J Gen Microbiol 139 : 2965 2972.
3. Bowman CC Clements JD (2001) Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids. Infect Immun 69 : 1528 1535.
4. Boyaka PN, Ohmura M, Fujihashi K, Koga T, Yamamoto M, Kweon M-N, Takeda Y, Jackson RJ, Kiyono H, Yuki Y McGhee JR (2003) Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit. J Immunol 170 : 454 462.
5. Brunham RC Peeling RW (1994) Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agent Dis 3 : 218 233.
6. Brunham RC Zhang DJ (1999) Transgene as vaccine for Chlamydia. Am Heart J 138 : S519 S522.
7. Cotter TW, Meng Q, Shen Z.-L, Zhang Y-X, Su H Caldwell HD (1995) Protective efficacy of outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun 63 : 4704 4714.
8. Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE Byrne GI (1997) Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun 65 : 2145 2152.
9. Eko F, Lubitz W, McMillian L, Ramey K, Moore T, Ananaba GA, Lyn D, Black CM Igietseme JU (2003) Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine 21 : 1694 1703.
10. Eko FO, Mayr UB, Attridge SR Lubitz W (2000) Characterization and immunogenicity of Vibrio cholerae ghosts expressing toxin-coregulated pili. J Biotechnol 83 : 115 123.
11. Eko FO, He Q, Brown T et al 2004) A novel recombinant multisubunit vaccine against chlamydia. J Immunol 173 : 3375 3382.
12. Elson CO, Holland SP, Dertzbaugh MT, Cuff CF Anderson AO (1995) Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J Immunol 154 : 1032 1040.
13. George-Chandy A, Eriksson K, Lebens M, Nordstorm I, Schon E Holmgren J (2001) Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 69 : 5716 5725.
14. Gockel CM, Baob S Beagley KW (2000) Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract. Molecular Immunology 37 : 537 544.
15. Hajishengallis G, Hollingshead SK, Koga T Russell MW (1995) Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 154 : 4322 4332.
16. He Q, Martinez-Sobrido L, Eko FO, Palese P et al 2007) Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology 122 : 28 37.
17. Holmgren J, Jertborn M, Svennerholm A-M, Sack D Clemens J (1990) The oral B subunit/inactivated whole cell vaccine. New Generation Vaccines (Woodrow G Levine M, eds), pp. 289 304. Marcel Dekker Inc., New York.
18. Igietseme JU Rank RG (1991) Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect Immun 59 : 1346 1351.
19. Igietseme JU, Uriri IM, Kumar SN, Ananaba GA, Ojior OO, Momodu IA, Canadal DH Black CM (1998) Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun 66 : 4030 4035.
20. Igietseme JU, Black CM Caldwell HD (2002) Chlamydia vaccines: strategies and status. BioDrugs 16 : 19 35.
21. Igietseme JU, Eko FO Black CM (2003) Contemporary approaches to designing and evaluating vaccines against Chlamydia. Expert Rev Vaccines 2 : 129 146.
22. Igietseme JU, Eko FO, He Q Black CM (2004) Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens. Expert Rev Vaccines 3 : 23 34.
23. Jechlinger W, Haller C, Resch S, Hofmann A, Szostak MP Lubitz W (2005) Comparative immunogenicity of the Hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine 23 : 3609.
24. Johansson E-L, Rask C, Fredriksson M, Eriksson K, Czerkinsky C Holmgren J (1998) Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 66 : 514 520.
25. Johansson M, Schon K, Ward M Lycke N (1997a) Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun 65 : 1032 1044.
26. Johansson M, Schon K, Ward M Lycke N (1997b) Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for human? Scand J Immunol 46 : 546 552.
27. Kelly KA (2003) Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms. Int Rev Immunol 22 : 3.
28. Kloos DU, Stratz M, Guttler A, Steffan RJ Timmis KN (1994) Inducible cell lysis system for the study of natural transformation and environmental fate of DNA release and cell death. J Bacteriol 176 : 7352 7361.
29. Knight SC, Iqball S, Woods C, Stagg A, Ward ME Tuffrey M (1995) A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo. Immunology 85 : 8 15.
30. Lenschow DJ, Walunas TL Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14 : 233 258.
31. Loomis WP Starnbach MN (2002) T cell responses to Chlamydia trachomatis. Curr Opin Microbiol 5 : 87.
32. Luci C, Hervouet C, Rousseau D, Holmgren J, Czerkinsky C Anjuere F (2006) Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol 176 : 2749 2757.
33. Macmillan L, Ifere G, He Q, Igietseme JU, Keller K, Okenu D Eko F (2007) A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes. FEMS Immunol Med Microbiol 49 : 46 55.
34. + T cells. Infect Immun 69 : 252 261.
35. Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, Eko FO Igietseme JU (2002) Fc receptor regulation of protective immunity against Chlamydia trachomatis. Immunology 105 : 213 221.
36. Moore T, Ekworomadu C, Eko F et al 2003) Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. J Infect Dis 188 : 617 624.
37. Morrison R Caldwell H (2002) Immunity to murine chlamydial genital infection. Infect Immun 70 : 2741 2751.
38. Morrison SG, Su H, Caldwell HD Morrison RP (2000) Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4+ T cells but not CD8+ T cells. Infect Immun 68 : 6979 6987.
39. Pal S, Luke CJ, Barbour AG, Peterson EM de la Maza LM (2003) Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge. Vaccine 21 : 1455 1465.
40. Pizza M, Giuliani MM, Fontana MR, Monaci E, Douce G, Dougan G, Mills KHG, Rappuoli R Del Guidice G (2001) Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants. Vaccine 19 : 2534.
41. Ramsey KH, Soderberg LSF Rank RG (1988) Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun 56 : 1320 1325.
42. Rank RG Batteiger BE (1989) Protective role of serum antibody in immunity to chlamydial genital infection. Infect Immun 57 : 299 301.
43. Riedmann EM, Kyd JM, Cripps AW Lubitz W (2007) Bacterial ghosts as adjuvant particles. Expert Rev Vaccines 6 : 241 253.
44. Schachter J Grayston JT (1998) Epidemiology of human Chlamydial infections. Chlamydial Infections (Stephens RS, Byrne GI Christiansen G., et al (eds), pp. 3 10. Berkeley, San Francisco, CA.
45. Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK Scissum-Gunn K (2006) Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection. Vaccine 24 : 1213.
46. Skelding KA, Hickey DK, Horvat JC, Bao S, Roberts KG, Finnie JM, Hansbro PM Beagley KW (2006) Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection. Vaccine 24 : 355.
47. Spangler B (1992) Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 56 : 622 647.
48. Stagg AJ (1998) Vaccines against Chlamydia: approaches and progress. Mol Med Today 4 : 166 173.
49. Su H, Parnell M Caldwell HD (1995) Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against genital tract infection. Vaccine 13 : 1023 1032.
50. Su H, Messer R, Whitmire W, Fischer E, Portis JC Caldwell HD (1998) Vaccination against Chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J Exp Med 188 : 809 818.
51. Tuffrey M, Alexander I, Conlan W, Woods C Ward M (1992) Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of C. trachomatis by prior immunization with recombinant serovar L1 major outer membrane protein. Eur J Immunol 23 : 1169 1172.
52. Wu H-Y Russell MW (1998) Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine 16 : 286.
53. Zhang Y-X, Stewart SJ Caldwell HD (1989) Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun 57 : 636 638.